Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in United States, automatically classified by Maddy, our AI policy reader.

Total bills
3,118
119th Congress
Top supporter
Alan Armstrong
83% support rate
Top opponent
Ashley Moody
20% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in United States

Legislators moving healthcare in United States
Legislator Party Stance Support rate Decisive votes
AA
Alan Armstrong Senate
R
Strong +
83% 6
Mazie K. Hirono
Mazie K. Hirono Senate
D
Strong +
80% 20
Peter Welch
Peter Welch Senate
D
Strong +
80% 20
Ron Wyden
Ron Wyden Senate
D
Strong +
80% 20
Alex Padilla
Alex Padilla Senate
D
Support
74% 19
Ashley Moody
Ashley Moody Senate
R
Strong −
20% 20
Rick Scott
Rick Scott Senate
R
Strong −
20% 20
Rand Paul
Rand Paul Senate
R
Oppose
25% 20
Tommy Tuberville
Tommy Tuberville Senate
R
Oppose
26% 19
Bill Hagerty
Bill Hagerty Senate
R
Oppose
28% 18
Showing 271–280 of 3,118 bills

All healthcare bills

in committee · United States · House Jul 15, 2026

HR 9709: Medicare Premiums Reduction Act of 2026

This bill, known as the Medicare Premiums Reduction Act of 2026, aims to lower the income thresholds used to calculate extra monthly premiums for Medicare Part B. It directly affects Medicare beneficiaries whose income exceeds specific limits, currently set at $85,000 for individuals and $170,000 for couples, by raising these limits to $171,000 and $205,000 respectively for the years 2027 and beyond. The legislation also adjusts the percentage of income used to determine these premiums, introducing new higher rates for those with modified adjusted gross income exceeding $205,000. By modifying the Social Security Act, the bill ensures that fewer high-income earners will be subject to the additional Part B surcharge starting in 2027.
Sub-Topics Medicare
in committee · United States · House Jul 15, 2026

HR 9699: Drug Deal Disclosure Act

The Drug Deal Disclosure Act requires the Department of Health and Human Services to publicly release records of specific agreements between the federal government and major drug manufacturers starting in 2025. These agreements must include provisions such as offering lower drug prices based on international rates, providing discounts through government platforms like TrumpRx, or receiving special exemptions from import duties and regulatory reviews. While the bill mandates that most documents be made available in a searchable format, it allows the government to withhold only specific confidential pricing details if legally required by foreign laws or court orders, provided a justification is published. Additionally, the law directs the Congressional Budget Office and the Government Accountability Office to analyze the economic and budgetary impacts of these deals, including effects on Medicare, Medicaid, and drug competition.
Sub-Topics Medicaid Medicare
in committee · United States · House Jul 23, 2026

HRES 1458: Recognizing July 28, 2026, as "World Hepatitis Day".

This resolution formally recognizes July 28, 2026, as World Hepatitis Day to raise awareness about the global impact of hepatitis B and C. It highlights the urgent need to address these viral infections, which cause significant liver disease and death worldwide and in the United States. The bill calls for increased public education, expanded access to vaccines and treatments, and stronger collaboration between federal and local health agencies to eliminate new infections.
in committee · United States · House Jul 22, 2026

HR 9867: Expand the Behavioral Health Workforce Now Act

The Expand the Behavioral Health Workforce Now Act directs the Secretary of Health and Human Services to issue guidance to states within 12 months of enactment. This guidance will outline strategies to improve the education, training, recruitment, and retention of mental health and substance use disorder care providers participating in Medicaid and CHIP programs. A specific focus of these strategies is to enhance the capacity of the workforce in rural and underserved areas. The act also specifies that the guidance should explore how states can use existing federal waivers and authorities to achieve these workforce goals.
in committee · United States · Senate Jul 16, 2026

S 5013: Veteran Acquired Brain Injury Caregiving Act

The Veteran Acquired Brain Injury Caregiving Act establishes a five-year pilot program allowing veterans with acquired brain injuries to use existing Veteran-Directed Care funds to hire care from specific nonprofit organizations. The Department of Veterans Affairs must select at least five medical centers to administer this program and will report annually on the number of participating veterans and nonprofits, along with an evaluation of clinical outcomes and satisfaction. This legislation directly affects veterans who have been clinically assessed for acquired brain injuries and are already eligible for the Veteran-Directed Care program, expanding their options for care providers.
in committee · United States · Senate Jul 15, 2026

S 4994: ONSHORE Manufacturing Act

The ONSHORE Manufacturing Act creates three new tax credits to financially encourage the domestic production of essential medical supplies and equipment. The first credit provides a percentage of a company's taxable income based on wages paid to workers manufacturing specific drugs, devices, and ingredients listed as critical for national security or defense. The second and third credits offer tax breaks for businesses that purchase and install advanced machinery or environmental compliance equipment used to produce these same medical products within the United States. These incentives are designed to support companies that manufacture specified medical goods in whole or significant part domestically, with the benefits applying to taxable years beginning after December 31, 2026. Additionally, the bill requires several federal agencies to submit annual reports to Congress starting in 2027 to track how these credits affect supply chain resiliency and adherence to domestic procurement laws.
Sub-Topics Procurement
in committee · United States · House Jul 15, 2026

HR 9703: Improving Access to Transfusion Care for Hospice Patients Act of 2026

This bill directs the Centers for Medicare & Medicaid Services to test a new payment model that allows blood transfusions for hospice patients to be billed separately from the standard daily hospice rate. Under this proposed change, Medicare would reimburse these transfusions at the same rate used when they are provided outside of a hospice setting. The legislation requires the agency to evaluate the model by comparing patient outcomes, such as hospital visits and chemotherapy use, between those receiving the new payment structure and similar patients under the current system. This initiative aims to determine if separating the payment for blood transfusions impacts care delivery and resource utilization for individuals receiving end-of-life care.
in committee · United States · House Jul 15, 2026

HR 9696: Saving Lives and Reducing Health Care Waste by Improving Diagnosis in Medicine Act

This bill establishes a comprehensive federal program to reduce diagnostic errors and improve patient safety by funding research, creating new research centers, and developing standardized data systems. It directs the Agency for Healthcare Research and Quality to launch a multi-year initiative that includes an advisory committee with patient representatives to design strategies for preventing medical mistakes and reducing associated health care costs. A key provision creates a voluntary reporting system for patients to share experiences of diagnostic errors without fear of legal repercussions, while also forming an interagency council to coordinate efforts across various health departments. The legislation authorizes significant funding over several years to support these research activities, data standardization, and the implementation of tools that leverage artificial intelligence and data science to enhance diagnostic accuracy.
in committee · United States · House Jul 14, 2026

HR 9669: FACT Pilot Program Act

This bill creates a five-year pilot program to provide grants to states and local governments for expanding Forensic Assertive Community Treatment teams. These specialized teams offer intensive, round-the-clock support including mental health care, addiction treatment, and housing assistance to individuals with serious mental illness who are involved with the criminal justice system. The program requires teams to include a mix of psychiatrists, employment specialists, criminal justice partners, and peer specialists with lived experience. Additionally, the legislation authorizes funding for a study by the National Academies to evaluate the program's effectiveness and develop guidelines for scaling it up.
in committee · United States · House Jul 14, 2026

HR 9661: Expedited Access to Biosimilars Act

The Expedited Access to Biosimilars Act modifies federal regulations to streamline the approval process for biosimilar drugs, which are lower-cost versions of existing biologic medicines. The bill requires manufacturers to conduct specific studies on how the drug behaves in the body and how the immune system reacts to it, while limiting the need for additional large-scale clinical trials unless the FDA explicitly determines they are necessary. To ensure transparency, the law mandates that the FDA must provide written notice to drug sponsors within 60 days regarding whether extra studies are required. These changes aim to reduce the time and cost involved in bringing biosimilars to market, potentially increasing patient access to affordable treatment options.
Showing 271 to 280 of 3,118 bills
Previous 1 … 27 28 29 … 312 Next